Sorenson Launches Spanish Language Option for ntouch iOS
SALT LAKE CITY, May 12, 2022 (GLOBE NEWSWIRE) — Today, Sorenson, the world’s leading provider…
News
GlobalBlock to Partake in H.C. Wainwright 2022 Global Investment Conference
Vancouver, British Columbia–(Newsfile Corp. – May 12, 2022) – GlobalBlock Digital Asset Trading Limited (TSXV:…
New Best-selling Book, Visionary Leadership in Healthcare, Highlights Importance of Press Ganey’s Compassionate Connected Care™ and Human-centric Insights
Press Ganey leaders unveil pivotal strategies for redesigning healthcare BOSTON–(BUSINESS WIRE)–Healthcare transformation isn’t going to…
Faraday Future Marks Production Milestone #5 at its Hanford, Calif. Manufacturing Facility, Remains on Schedule to Launch in Q3 2022
Milestone #5 signifies the start of all major mechanical, electrical, and plumbing (MEP) systems to…
“Hot Hardware and Hand Tools” Webinar Spotlights Taiwan Excellence Award Winners and Their Innovations
May 20th Virtual Event Offers Buyers First Look at Advanced Wrenches and Torque Tools, Ingenious…
Autonomy Expands EV Subscriptions To Fresno, Unlocking Accessible Green Mobility to More Californians
SANTA MONICA, Calif.–(BUSINESS WIRE)–Autonomy, the electric vehicle subscription company that offers the cheapest, fastest and…
Institutional Property Advisors Negotiates $260 Million Multifamily Asset Sale in Scottsdale
SCOTTSDALE, Ariz.–(BUSINESS WIRE)–Institutional Property Advisors (IPA), a division of Marcus & Millichap (NYSE: MMI), announced…
JERA Americas to Acquire Thermal Power Portfolio in New England
–Facilities will maintain grid reliability as Company moves forward with clean energy vision– HOUSTON–(BUSINESS WIRE)–JERA…
Doordash Takes Huge Bite Out of Competition with Nearly 300% Increase in Purchases, Say Emburse Expense Data
‘Most Expensed Meals’ data reveals which food brands American workers favor; Starbucks, McDonald’s top the…
CORRECTING and REPLACING Paracrine Announces Appointment of Biotech Veteran David H. Crean, Ph.D. to the Board of Directors
SAN DIEGO–(BUSINESS WIRE)–Please replace the release with the following corrected version due to multiple revisions….
Lang.ai Raises $10.5M Series A to Help CX Teams Turn Conversations Into Insights and Automation
SAN FRANCISCO–(BUSINESS WIRE)–Lang.ai has announced its completion of a $10.5M Series A led by Nava…
KBRA Assigns Preliminary Ratings to Carvana Auto Receivables Trust 2022-P2
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA assigns preliminary ratings to five classes of notes issued by Carvana Auto…
Intelligent Waves Partners with Horizon3.ai’s NodeZero to Empower Special Operators with Next-Gen Cybersecurity Resilience in DevOps
RESTON, Va.–(BUSINESS WIRE)–$IWLLC #CEOs—Intelligent Waves (IW), a leading IT integrator that provides mission-focused, multi-domain operational…
Scibids Helps Charlotte Tilbury Beauty Reduce Cost Per Acquisition (CPA) by 29% With Custom Bidding
Within two months the beauty brand saw a 60% increase in conversion rate and doubled…
Schneider Electric’s Award-Winning Square D Energy Center Now Available for Order
Smartest, most-awarded panel on the market now available for order from electrical distribution centers Innovative…
Apellis Announces Seven Abstracts in PNH to be Presented at the European Hematology Association Congress
Accepted abstracts include an oral presentation highlighting quality of life improvements with EMPAVELI® (pegcetacoplan) WALTHAM, Mass.,…
Autolus Therapeutics to Present Four Clinical Data Updates at the European Hematology Association Congress
– AUTO4: oral presentation on initial clinical experience in peripheral T cell lymphoma– AUTO1/22: oral…
CORRECTION: Evelo Biosciences Announces First Quarter 2022 Financial Results and Business Highlights
CAMBRIDGE, Mass., May 12, 2022 (GLOBE NEWSWIRE) — In a release issued under the same…
Mustang Bio Announces Results from Follicular Lymphoma Cohort of Ongoing Phase 1/2 Clinical Trial of MB-106, CD20-Targeted CAR T Therapy, Selected for Oral Presentation at European Hematology Association 2022 Hybrid Congress
Favorable safety profile, high overall response and complete response rates, and CAR T persistence observed…
CRISPR Therapeutics Announces Oral Presentation of New Clinical Data on Anti-CD70 Allogeneic CAR-T Therapy CTX130™ for Patients with T-cell Lymphoma at the Annual European Hematology Association (EHA) 2022 Hybrid Congress
ZUG, Switzerland and CAMBRIDGE, Mass., May 12, 2022 (GLOBE NEWSWIRE) — CRISPR Therapeutics (Nasdaq: CRSP),…